TY - JOUR
T1 - Cognitive Syndromes Associated with Movement Disorders
AU - Morris, John C.
AU - Goldman, Jennifer G.
AU - Holden, Samantha K.
N1 - Funding Information:
RELATIONSHIP DISCLOSURE: Dr Goldman has received personal compensation in the range of $500 to $4999 for serving as an officer or member of the board of directors for the Parkinson’s Foundation Scientific Advisory Board. The institution of Dr Goldman has received research/grant support from Acadia Pharmaceuticals, the American Parkinson’s Disease Association, Lewy Body Dementia Association Research Center of Excellence, Michael J. Fox Foundation for Parkinson’s Research, and the Parkinson’s Foundation. The institution of Dr Holden has received research support from Michael J. Fox Foundation for Parkinson’s Research.
Publisher Copyright:
© Lippincott Williams & Wilkins.
PY - 2022/6/1
Y1 - 2022/6/1
N2 - PURPOSE OF REVIEW This article reviews the recognition and management of cognitive syndromes in movement disorders, including those with parkinsonism, chorea, ataxia, dystonia, and tremor. RECENT FINDINGS Cognitive and motor syndromes are often intertwined in neurologic disorders, including neurodegenerative diseases such as Parkinson disease, atypical parkinsonian syndromes, Huntington disease, and other movement disorders. Cognitive symptoms often affect attention, working memory, and executive and visuospatial functions preferentially, rather than language and memory, but heterogeneity can be seen in the various movement disorders. A distinct cognitive syndrome has been recognized in patients with cerebellar syndromes. Appropriate recognition and screening for cognitive changes in movement disorders may play a role in achieving accurate diagnoses and guiding patients and their families regarding progression and management decisions. SUMMARY In the comprehensive care of patients with movement disorders, recognition of cognitive syndromes is important. Pharmacologic treatments for the cognitive syndromes, including mild cognitive impairment and dementia, in these movement disorders lag behind the therapeutics available for motor symptoms, and more research is needed. Patient evaluation and management require a comprehensive team approach, often linking neurologists as well as neuropsychologists, psychologists, psychiatrists, social workers, and other professionals.
AB - PURPOSE OF REVIEW This article reviews the recognition and management of cognitive syndromes in movement disorders, including those with parkinsonism, chorea, ataxia, dystonia, and tremor. RECENT FINDINGS Cognitive and motor syndromes are often intertwined in neurologic disorders, including neurodegenerative diseases such as Parkinson disease, atypical parkinsonian syndromes, Huntington disease, and other movement disorders. Cognitive symptoms often affect attention, working memory, and executive and visuospatial functions preferentially, rather than language and memory, but heterogeneity can be seen in the various movement disorders. A distinct cognitive syndrome has been recognized in patients with cerebellar syndromes. Appropriate recognition and screening for cognitive changes in movement disorders may play a role in achieving accurate diagnoses and guiding patients and their families regarding progression and management decisions. SUMMARY In the comprehensive care of patients with movement disorders, recognition of cognitive syndromes is important. Pharmacologic treatments for the cognitive syndromes, including mild cognitive impairment and dementia, in these movement disorders lag behind the therapeutics available for motor symptoms, and more research is needed. Patient evaluation and management require a comprehensive team approach, often linking neurologists as well as neuropsychologists, psychologists, psychiatrists, social workers, and other professionals.
UR - http://www.scopus.com/inward/record.url?scp=85131651216&partnerID=8YFLogxK
U2 - 10.1212/CON.0000000000001134
DO - 10.1212/CON.0000000000001134
M3 - Review article
C2 - 35678400
AN - SCOPUS:85131651216
SN - 1080-2371
VL - 28
SP - 726
EP - 749
JO - CONTINUUM Lifelong Learning in Neurology
JF - CONTINUUM Lifelong Learning in Neurology
IS - 3
ER -